Clinical practice guidelines
Aim: To assist the Australian Cancer Network to produce up to date evidence-based clinical practice guidelines for the management of melanoma in line with NHMRC standards
Methods
- Production of handbook to guide clinicians through the NHMRC process
- Education for the clinicians in NHMRC methods
- Specification of the clinical guideline questions
- Systematic searches and retrieval of literature for 90+ questions
- Provision of advice on critical appraisal and format for the guidelines
- Review of guideline content and assistance with the public consultation process
Part of this project was conducted while two Network staff members were employed through Sydney Health Projects Group at the University of Sydney. The remainder of the project was funded and conducted through the Network in assocation with the Australian Cancer Network.
Status: Clinical practice guidelines for the management of melanoma in Australia and New Zealand were completed and endorsed by NHMRC and the New Zealand Guidelines Group in November 2008.
Please click here to download the full file of Clinical Practice Guidelines Management of Melanoma
Erratum for the first printing of the Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand
Page 159, Table 27.2 Survival Rates for Melanoma TNM and Staging Categories.
Erratum corrected 5/6/09.
Alternatively you may download the following individual files:
- Guidelines Cover Page
- Guidelines Contents
- Guidelines Foreword
- Guidelines New Zealand Foreword
- Guidelines Preface
- Guidelines Executive Summary
- Guidelines Introduction
- Guidelines Summary of clinical practice recommendations
- Guidelines Chapter 1 Prevention
- Guidelines Chapter 2 Population based whole body skin screening for melanoma
- Guidelines Chapter 3 Identification and management of high risk individuals
- Guidelines Chapter 4 Classification and staging of melanoma
- Guidelines Chapter 5 Clinical diagnosis
- Guidelines Chapter 6 Biopsy
- Guidelines Chapter 7 Histopathological reporting of cutaneous melanoma
- Guidelines Chapter 8 Appropriate investigations
- Guidelines Chapter 9 Congenital melanocytic naevi
- Guidelines Chapter 10 Lentigo maligna
- Guidelines Chapter 11 Treatment of primary melanoma
- Guidelines Chapter 12 Management of regional lymph nodes in melanoma
- Guidelines Chapter 13 Management of locoregionally recurrent melanoma
- Guidelines Chapter 14 Adjuvant systemic therapy for melanoma
- Guidelines Chapter 15 Treatment of disseminated melanoma
- Guidelines Chapter 16 Psychosocial issues in melanoma
- Guidelines Chapter 17 Palliative care in melanoma
- Guidelines Chapter 18 Multidisciplinary care of melanoma
- Guidelines Chapter 19 Follow up
- Guidelines Chapter 20 Clinical Trials
- Guidelines Chapter 21 Treatment of desmoplastic melanoma
- Guidelines Chapter 22 Mucosal melanoma
- Guidelines Chapter 23 Occult melanoma
- Guidelines Chapter 24 Ocular melanoma
- Guidelines Chapter 25 Melanoma in children
- Guidelines Chapter 26 Pregnancy and melanoma
- Guidelines Chapter 27 Prognostic factors and survival outcomes in cutaneous melanoma
Erratum: Page 159, Table 27.2 Survival Rates for Melanoma TNM and Staging Categories.
Erratum corrected 5/6/09. - Guidelines Chapter 28 Complementary and alternative medicine
- Guidelines Chapter 29 Melanoma in specific populations in Australia
- Guidelines Chapter 30 Melanoma in Maori and melanoma in Pacific peoples in New Zealand
- Guidelines Appendices
- Guidelines Abbreviations and glossary
